Construction and evaluation of a eukaryotic expression plasmid for stable delivery using attenuated Salmonella

Microbial Pathogenesis

Volumn 34, Issue 3, 2003, Pages 115-119

  Garmory, Helen S ^a   Titball, Richard W ^a,b   Brown, Katherine A ^c   Bennett, Alice M ^a  

^a DEFENCE SCIENCE AND TECHNOLOGY LABORATORY   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Copy number; Expression plasmid; Salmonella

Indexed keywords

BETA GALACTOSIDASE; IMMUNOGLOBULIN G; NAKED DNA; PROTEIN ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN PRESENTATION; ARTICLE; BACTERIAL STRAIN; BACTERIUM DETECTION; CONTROLLED STUDY; CYTOMEGALOVIRUS; DRUG DELIVERY SYSTEM; DRUG SCREENING; DRUG STABILITY; EUKARYOTE; FEMALE; HETEROLOGOUS EXPRESSION; IN VIVO STUDY; INOCULATION; MOLECULAR CLONING; MOUSE; NONHUMAN; PEYER PATCH; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; SALMONELLA; SALMONELLA ENTERICA; SPLEEN;

EUKARYOTA; SALMONELLA; SALMONELLA ENTERICA; TYPHIMURIUM;

EID: 0037333160     PISSN: 08824010     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0882-4010(02)00176-6     Document Type: Article

References (12)

1. Davis H.L. Plasmid DNA expression systems for the purpose of immunization. Curr Opin Biotech. 8:1997;635-640.
2. Weiss S., Krusch S. Bacteria-mediated transfer of eukaryotic expression plasmids into mammalian host cells. Biol Chem. 382:2001;533-541.
3. Darji A., Guzmán C.A., Gerstel B., et al. Oral somatic transgene vaccination using attenuated S. typhimurium. Cell. 91:1997;765-775.
4. Garmory H.S., Brown K.A., Titball R.W. Salmonella vaccines for use in humans: present and future perspectives. FEMS Microbiol Rev. 2002;339-353.
5. Sirard J.-C., Niedergang F., Kraehenbuhl J.-P. Live attenuated Salmonella: a paradigm of mucosal vaccines. Immunol Rev. 171:1999;5-26.
6. Paglia P., Medina E., Arioli I., Guzman C.A., Colombo M.P. Gene transfer in dendritic cells, induced by oral DNA vaccination with Salmonella typhimurium, results in protective immunity against a murine fibrosarcoma. Blood. 92:1998;3172-3176.
7. Paglia P., Terrazzini N., Schulze K., Guzmán C.A., Colombo M.P. In vivo correction of genetic defects of monocyte/macrophages using attenuated Salmonella as oral vectors for targeted gene delivery. Gene Ther. 7:2000;1725-1730.
8. Darji A., zur Lage S., Garbe A.I., Chakraborty T., Weiss S. Oral delivery of DNA vaccines using attenuated Salmonella typhimurium as carrier. FEMS Immunol Med Microbiol. 27:2000;341-349.
9. + T-cells develop after intragastric vaccination with a Salmonella env DNA vaccine vector. Vaccine. 20:2002;623-629.
10. Weiss S., Krusch S. Bacteria-mediated transfer of eukaryotic expression plasmids into mammalian host cells. Biol Chem. 382:2001;533-541.
11. Stoker N.G., Fairweather N., Spratt B.G. Versatile low-copy-number plasmid vectors for cloning in Escherichia coli. Gene. 18:1982;335-341.
12. + for all three chromosomally located systems of DNA restriction and modification. J Bacteriol. 156:1983;471-474.